Learn / KLRA
NASDAQ: KLRA
Kailera Therapeutics (KLRA) stock, explained like you're 5
Kailera Therapeutics trades on the Nasdaq under the ticker KLRA. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.5 billion dollars.
- Ticker
- KLRA
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 1.5 billion dollars
Is Kailera Therapeutics a small, medium or large cap company?
No. Kailera Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.5 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Kailera Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves KLRA stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Kailera Therapeutics, Inc. (KLRA) Options Chain Yahoo Finance (Yahoo! Finance Canada)
- KLRA Stock Price, Quote & Chart (ChartMill)
- Kailera Therapeutics Inc. (KLRA) Stock Price | Live Quotes & Charts | NASDAQ (Timothy Sykes)
- symbol__ Stock Quote Price and Forecast (CNN)
- Certain Options of Kailera Therapeutics, Inc. are subject to a Lock Up Agreement Ending on 14 OCT 2026. (marketscreener.com)
Follow KLRA in your daily brief
Each trading day at 5 PM ET we post what happened to Kailera Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow KLRA
Questions about Kailera Therapeutics stock
What does Kailera Therapeutics do?
Kailera Therapeutics trades on the Nasdaq under the ticker KLRA. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.5 billion dollars.
What is the ticker symbol for Kailera Therapeutics?
Kailera Therapeutics trades under the ticker KLRA on the Nasdaq.
What is Kailera Therapeutics's market cap?
Kailera Therapeutics is a small cap stock with a market cap of about 1.5 billion dollars.
How does Kailera Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves KLRA stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow KLRA stock every day?
Add KLRA to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.